Revenue (Tables)

3 Months Ended

Dec. 31, 2022

Revenue From Contract With Customer [Abstract]

Summary of Revenues Disaggregated by Product Classification and Reportable Segment

The following table presents the Company’s revenues disaggregated by product classification and by reportable segment.

	Three Months Ended December 31,
(In thousands)	2022		2021
Medical Device
Product sales	$	8,380	$	6,788
Royalties		7,409		6,886
License fees		1,356		1,213
Research, development and other		1,873		2,021
Medical Device Revenue		19,018		16,908
In Vitro Diagnostics
Product sales		5,854		5,556
Research, development and other		61		539
In Vitro Diagnostics Revenue		5,915		6,095
Total Revenue	$	24,933	$	23,003